NEXT
Sign in to follow
Search Results

0 results for 'Noerr'

You can use to get even better search results Noerr
October 12, 2005 | New York Law Journal

Pfizer's Cholesterol Gambit: Dodging the Antitrust Laws?

Gordon Schnell, a partner at Constantine Cannon, discusses Pfizer's plan to submit its unique new cholesterol drug for FDA approval only in combination with another of its drugs, thereby protecting the latter from competition. However, the deference most courts give to the FDA to regulate the manner in which drugs are sold would likely immunize Pfizer from antitrust liability over this tying arrangement, creating a regulatory loophole for the pharmaceutical industry.
11 minute read
Posner v. Lewis, 103496/09
Publication Date: 2010-12-10
Practice Area: Torts
Industry:
Court: Appellate Division, First Department
Judge: Before: Peter Tom, J.P.; Richard T. Andrias, Eugene Nardelli, Dianne T. Renwick, Nelson S. Román, JJ.
Case number: 103496/09

Cite as: Posner v. Lewis, 103496/09, NYLJ 1202475950215, at *1 (App. Div. 1st., Decided December 9, 2010)Before: Peter Tom, J.P.; Richard T. Andrias, Eugene Nar

June 25, 2001 | The Legal Intelligencer

news in brief

Beware of Hacker Who Hates LawyersPhiladelphia - Somebody out there doesn't like lawyers, and he or she is demonstrating that dislike through a computer virus that is triggered by a handful of legal words such as "trial judge," "affirmed," "guilty" ...
7 minute read
June 21, 2013 | The Legal Intelligencer

Judge Approves $35 Million Flonase Antitrust Settlement

Days after approving a $150 million class action settlement between direct purchasers of nasal spray Flonase and manufacturer GlaxoSmithKline, a federal judge has approved a $35 million settlement between GSK and the indirect purchasers of the drug.
4 minute read
September 04, 2009 | New York Law Journal

Louisiana Wholesale Drug Co. Inc. v. Sanofi-Aventis

Drug Firm's Citizen Petition to Delay Generics' Approval Not 'Objectively Baseless'; Sherman Act Not Breached
2 minute read
October 17, 2008 | New York Law Journal

Louisiana Wholesale Drug Co. Inc. v. Sanofi-Aventis

Drug Maker's Sham 'Citizen Petition' to Block Approval For Rivals' Generic Drugs Leads to Judgment Denial
1 minute read
December 02, 2009 | New Jersey Law Journal

Daily Decision Service Alert: Vol. 18, No. 233 - December 2, 2009

Daily decision alert.
10 minute read
October 08, 2013 | New York Law Journal

FTC Divided on Effect of Seeking Injunctions Over Patents

In their Antitrust Trade and Practice column, Shepard Goldfein and James Keyte, partners at Skadden, Arps, Slate, Meagher & Flom write that in the last year, both the FTC and the Antitrust Division of the DOJ have been particularly hawkish with respect to limiting standard essential patent holders' rights to seek injunctive relief against alleged patent violators. However, recent statements from FTC Commissioner Joshua Wright suggest that antitrust officials may not be as aligned on the issue as it previously appeared.
14 minute read
May 26, 2005 | New York Law Journal

Antitrust

William T. Lifland, senior counsel at Cahill Gordon & Reindel, exmaines recent rulings, including the Ninth Circuit's finding that a ticketing service company's exclusive contracts with venues did not unreasonably restrain trade.
8 minute read
March 09, 1998 | New Jersey Law Journal

Daily Decision Alert: Vol. 6, No. 45 -- March 9, 1998

11 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Leveraging Technology to Improve Employee Engagement and Client Satisfaction

    Brought to you by CARET Legal

    Download Now

  • How to Choose Your Legal Operations Software: Key Considerations and Expert Tips

    Brought to you by DiliTrust

    Download Now

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now